Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
$12.96
+0.5%
$10.17
$7.00
$14.73
$483.26M1.2443,152 shs38,327 shs
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
$7.35
-0.3%
$2.06
$0.26
$3.77
$193.16M2.06168,718 shs45,454 shs
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
$8.53
+7.6%
$8.01
$3.22
$12.50
$654.74M1.08230,894 shs226,513 shs
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
$1.57
+5.4%
$1.31
$5.70
$9.99
$78.99MN/A141,126 shs136,210 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
0.00%-3.20%+35.35%+32.43%-10.40%
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
-0.27%+0.55%-1.87%-5.77%+37.13%
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
+8.25%+6.09%+9.22%-10.59%+134.34%
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
+6.80%+12.95%+3.97%+38.94%+12.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
2.5863 of 5 stars
0.04.02.50.00.00.03.1
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
1.2671 of 5 stars
0.04.00.04.70.00.80.6
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
2.1969 of 5 stars
3.50.00.00.03.40.00.6
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
0.00
N/AN/AN/A
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
0.00
N/AN/AN/A
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
3.00
Buy$14.0064.13% Upside
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
$14.17B0.03$2.23 per share5.80$2.23 per share5.81
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
$287M0.67N/AN/A$8.96 per share0.82
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
$881.44M0.83N/AN/A$5.19 per share1.64
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
N/AN/A$0.01 per share111.14($0.59) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
$59.29M$0.799.267.76N/A6.65%83.11%10.89%10/23/2025 (Estimated)
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
-$317M-$5.79N/AN/A-141.03%-81.98%-52.13%N/A
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
-$26.95M-$0.43N/A106.63N/A-3.98%-5.88%-3.63%N/A
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
$2.70MN/A0.00N/AN/A-22.81%-4.99%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
$1.027.87%N/A129.11%N/A
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
N/AN/AN/AN/AN/A
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
N/AN/AN/AN/AN/A
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
N/AN/AN/AN/AN/A

Latest LOGC, MYTE, BWMX, and VGII Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2025
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
$0.25667.83%8/11/20258/12/20258/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
3.85
1.07
0.50
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
N/A
31.60
31.60
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
0.09
1.78
0.22
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
N/A
0.18
0.18
CompanyEmployeesShares OutstandingFree FloatOptionable
Betterware de México, S.A.P.I. de C.V. stock logo
BWMX
Betterware de México, S.A.P.I. de C.V.
1,27037.32 millionN/AOptionable
LogicBio Therapeutics, Inc. stock logo
LOGC
LogicBio Therapeutics
6226.28 million24.16 millionOptionable
MYT Netherlands Parent B.V. stock logo
MYTE
MYT Netherlands Parent B.V.
1,24085.70 million83.65 millionOptionable
Virgin Group Acquisition Corp. II stock logo
VGII
Virgin Group Acquisition Corp. II
N/A50.31 millionN/ANot Optionable

Recent News About These Companies

A Deeper Look At The Virgin America Sale
Seiko Group Corp.
Bowen Acquisition Corp BOWN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Betterware de México, S.A.P.I. de C.V. stock logo

Betterware de México, S.A.P.I. de C.V. NASDAQ:BWMX

$12.96 +0.07 (+0.54%)
Closing price 08/15/2025 03:57 PM Eastern
Extended Trading
$13.10 +0.14 (+1.04%)
As of 08/15/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Betterware de México, S.A.P.I. de C.V. operates as a direct-to-consumer selling company in the United Staes and Mexico. It operates through two segments, Home Organization Products; and Beauty and Personal Care Products. The Home Organization Products segment provides a portfolio of products comprising kitchen and food preservation; home solutions; bedroom; bathroom; laundry and cleaning; wellness; and technology and mobility. The Beauty and Personal Care Products segment offers fragrances, colors, skin care products, and toiletries. It sells its products through catalogues, as well as distributes through a network of distributors, associates, leaders, and consultants to the end customers. The company is headquartered in El Arenal, Mexico. Betterware de México, S.A.P.I. de C.V. is a subsidiary of Campalier S.A. de C.V.

LogicBio Therapeutics stock logo

LogicBio Therapeutics NASDAQ:LOGC

LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

MYT Netherlands Parent B.V. stock logo

MYT Netherlands Parent B.V. NYSE:MYTE

$8.53 +0.60 (+7.57%)
As of 08/15/2025

MYT Netherlands Parent B.V., through its subsidiary, Mytheresa Group GmbH, operates a luxury e-commerce platform for fashion consumers in Germany, the United States, rest of Europe, and internationally. It offers womenswear, menswear, kids wear, and lifestyle products. The company sells clothes, bags, shoes, accessories, and fine jewelry through online and retail stores. It serves high-income luxury consumers. The company was founded in 1987 and is based in Munich, Germany.

Virgin Group Acquisition Corp. II stock logo

Virgin Group Acquisition Corp. II NYSE:VGII

$1.57 +0.08 (+5.37%)
As of 08/15/2025

Virgin Group Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. Virgin Group Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.